Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2021 Aug 7;93(12):6465–6467. doi: 10.1002/jmv.27241

Arboviral diseases and COVID‐19 coincidence: Challenges for Pakistan's derelict healthcare system

Muhammad H Butt 1,, Aqsa Safdar 1, Attiya Amir 1, Muhammad Zaman 1, Abrar Ahmad 1, Rana T Saleem 1, Shahzadi Misbah 1, Yusra H Khan 2, Tauqeer H Mallhi 2,
PMCID: PMC8427066  PMID: 34324213

Dear Editor,

Coronavirus Disease 2019 (COVID‐19) along with other infectious diseases has created a huge impact on the crumbling healthcare system in Pakistan. The relationship between co‐epidemics and cooccurrences has been previously reported in many studies and has raised the issue of continuous decimation. 1 , 2 According to the World Health Organization's epidemiological report, a total of 172,637,097 confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) positive along with 3,718,944 deaths have been reported worldwide till June 6, 2021. In Pakistan, the total cases have escalated to 930,511 and have taken approximately 21,000 lives. 3 With the rapid upsurge of COVID‐19 cases and devastating effect on the overburdened healthcare system in Pakistan, many viral diseases including dengue fever, zika, chikungunya, Crimean‐Congo hemorrhagic fever, Measles, and Poliomyelitis has become a significant challenge for health authorities. The National Institute of Health in Pakistan has issued a “high alert” on the cooccurrence of these diseases in the coming months. 4 Table 1 indicates the burden of various viral diseases along with COVID‐19 in Pakistan. It is pertinent to mention that Pakistan is in the endemic stage of arboviral infections and emergency preparedness is the need of the hour to avoid the catastrophic impact on the healthcare system. 13 Such catastrophic effects have been reported in many Asian countries and in Latin America where the COVID‐19 outbreak has been reported during the dengue season. 9 , 14 A recent study has reported that Brazil has undergone a severe surge of zika, dengue, and chikungunya cases during the ongoing COVID‐19 pandemic. 15 High alerts of arboviral infections create numerous logistic and critical challenges for the already worn‐out healthcare system in Pakistan. A stern, sensible and judicious action plan is required in haste to quell the aggravating dangers of cooccurrence.

Table 1.

Disease burden of COVID‐19, zika, dengue, and chikungunya

Viral disease Virus Incubation Period (days) First case in Pakistan Cases in Pakistan World‐wide cases Fatality rate (%) Reference
COVID‐19 SARS‐CoV‐2 2–14 2020 930,511 172,637,097 (2019–2021) [4, 6]
Chikungunya positive‐sense single‐stranded RNA chikungunya virus 2–12 1983 3000 in 2016 146,914 in 2016 0.1 [5, 7, 8]
Dengue virus Dengue Virus Serotypes (DEN1, DEN2, DEN3, DEN4) 3–14 1994 103,272 (2015–2020) 390 million every year <1 [5, 10]
Zika virus Virus transmitted by Aedes mosquitoes 3–14 1983 No cases in 2020 84,276 (2016–2019) 8.3 [11, 12]

The COVID‐19 and arboviral infections (zika, dengue, and chikungunya) share similar laboratory manifestations in their early‐stage, which compromise the definite diagnosis and lead to false‐positive reporting. Recently, numerous false‐positive cases have been reported in India, Singapore, Bangladesh, Pakistan, and Thailand during serological testing but later corroborated as COVID‐19. 9 , 16 , 17 Subsequently, misdiagnosis leads to inappropriate and irrational treatment which leads to an increased burden of arboviral infections with adverse clinical outcomes. 18

Pakistan is a developing country with an estimated population of around 216 million. Unexpectedly, population upsurge increased the growth rate up to 2.04% and increased the demand for resources such as intensive care units, beds in the hospital, laboratory equipment, doctors, nurses, pharmacists, and paramedical staff. 19 This population upsurge can lead to unplanned growth along with health risks, water dumping, drainage blocks, and stagnant water. All such issues create pernicious environments for the proliferation of arboviral infections. 20

Pakistan's healthcare system has experienced various challenges during the COVID‐19 pandemic including economic turmoil due to less health budget. These financial constraints lead to a shortage of workforce, ventilators, hospital beds, healthcare professionals, and laboratory equipment. As Pakistan has never planned to deal with public health issues that affect the healthcare system, proactive and stern measures are vital to control the ongoing situation. Following standard operating procedures (SOPs) during the lockdown and self‐quarantining will not only subside the upsurge of COVID‐19 infection but will also help to combat the other arboviral infection outbreaks. The increase in the prevalence of arboviral infections in low‐income and developing countries such as Pakistan is due to insufficient access to sanitation, water supply, and hygiene measures. These issues elevate the risk for vector reproduction that potentially and directly augment the arboviral infections along with COVID‐19. 21 , 22

Keeping in view the upsurging trend of arboviral infections and the intricate situation of outbreaks, the healthcare system of Pakistan is at risk with growing economic concerns. Suitable and potential measures must be taken under consideration to differentiate patients of COVID‐19 and arboviral infections with the appropriate diagnostic algorithm. The health authorities should consider appropriate policies for case management, initiate awareness campaigns, design vector control programs and make documentaries regarding disease prevention and safety protocols. Health authorities should have a proactive recruitment plan for clinicians to avoid any shortage at the time of co‐epidemics. The timely reporting of infectious cases by clinicians is of utmost importance to get accurate surveillance data. Moreover, hospital administration should focus on the development of treatment and diagnostic algorithms for such infections. Federal and provincial health authorities must increase laboratory facilities in consultation with foreign agencies and should take active measures to make sure the availability of required medications in the hospitals. Provincial authorities should make a plan to segregate patients so as to lessen upswings of infections and should also develop water management plans and cleaning of roads. Failure to develop programs and policies for viral diseases and lack of provision of newer facilities along with the impact of less healthcare budget can cause severe ramifications for Pakistan due to the derelict healthcare system. Taken together, prime consideration should be given to establishing separate wards for each disease, development of diagnostic and treatment algorithms, awareness campaigns among the public, availability of vital drugs in the health vicinities, aggressive monitoring, compliance with SOPs, and training of healthcare staff. Stern prospective measures will not only aid in tackling the situation of co‐epidemics but also help health authorities in their continuing efforts against COVID‐19.

CONFLICT OF INTERESTS

All authors declared that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

Muhammad H. Butt, Abrar Ahmad, and Tauqeer H. Mallhi were involved in conceptualizing the study. Aqsa Safdar, Attiya Amir, Rana T. Saleem, and Shahzadi Misbah were involved in the literature review and preparing the table. Muhammad H. Butt, Aqsa Safdar, and Muhammad Zaman were involved in the drafting of the letter. Yusra H. Khan and Tauqeer H. Mallhi critically revised the letter for final submission. All authors approved the final version for submission and publication of the content.

Contributor Information

Muhammad H. Butt, Email: hmdbut@ucp.edu.pk.

Tauqeer H. Mallhi, Email: tauqeer.hussain.mallhi@hotmail.com.

REFERENCES

  • 1. Butt MH, Ahmad A, Misbah S, Mallhi TH, Khan YH. Crimean‐Congo hemorrhagic fever and Eid‐Ul‐Adha: a potential threat during the COVID‐19 pandemic. J Med Virol. 2021;93(2):618‐619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ribeiro VST, Telles JP, Tuon FF. Arboviral diseases and COVID‐19 in Brazil: concerns regarding climatic, sanitation, and endemic scenario. J Med Virol. 2020;92(11):2390‐2391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. World Health Organization . Weekly epidemiological update on COVID‐19. June 8, 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---8-june-2021. Accessed June 10, 2021.
  • 4. National Institute of Health . Seasonal Awareness And Alert Letter (SAAL) for epidemic‐prone infectious diseases in Pakistan. 2021. https://www.nih.org.pk/wp-content/uploads/2021/04/50th-Issue-SAAL-Print-1.pdf. Accessed June 10, 2021.
  • 5. Misbah S, Ahmad A, Butt MH, Khan YH, Alotaibi NH, Mallhi TH. A systematic analysis of studies on coronavirus disease 19 (COVID‐19) from viral emergence to treatment. J Coll Physicians Surg Pak. 2020;30(6):9‐18. [DOI] [PubMed] [Google Scholar]
  • 6. Mallhi TH, Khan YH, Khan AH, Tanveer N, Qadir MI. First chikungunya outbreak in Pakistan: a trail of viral attacks. New Microbes New Infect. 2017;19:13‐14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. World Health Organization . Chikungunya fact sheet. 2020. https://www.who.int/news-room/fact-sheets/detail/chikungunya. Accessed June 29, 2021.
  • 8. Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT. Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines. 2012;11(9):1087‐1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Butt MH, Ahmad A, Misbah S, Mallhi TH, Khan YH. Dengue fever and COVID‐19 coinfection; a threat to public health for coepidemic in Pakistan. J Med Virol. 2021;93(2):671‐672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Moraes GH, de Fátima Duarte E, Duarte EC. Determinants of mortality from severe dengue in Brazil: a population‐based case‐control study. Am J Trop Med Hyg. 2013;88(4):670‐676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Bhargavi BS, Moa A. Global outbreaks of zika infection by epidemic observatory (EpiWATCH), 2016‐2019. Global Biosecurity. 2020;1(4). [Google Scholar]
  • 12. Wahid B, Ali A, Rafique S, Idrees M. Zika virus: is Pakistan next? Asian Pac J Trop Med. 2018;11(7):1–11. [Google Scholar]
  • 13. Badar N, Salman M, Ansari J, Ikram A, Qazi J, Alam MM. Epidemiological trend of chikungunya outbreak in Pakistan: 2016–2018. PLOS Neglected Trop Dis. 2019;13(4):e0007118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Magalhaes T. The endless challenges of arboviral diseases in Brazil. Trop Med Infect Dis. 2020;5(2):75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. do Rosário MS, de Siqueira IC. Concerns about COVID‐19 and arboviral (chikungunya, dengue, zika) concurrent outbreaks. Braz J Infect Dis. 2020;24(6):583‐584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Waterman SH, Paz‐Bailey G, San Martin JL, Gutierrez G, Castellanos LG, Mendez‐Rico JA. Diagnostic laboratory testing and clinical preparedness for dengue outbreaks during the COVID‐19 pandemic. Am J Trop Med Hyg. 2020;103(3):1339‐1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Bansal N, Bansal Y, Ralta A. Thrombocytopenia in COVID‐19 patients in Himachal Pradesh (India) and the absence of dengue false‐positive tests: insights for patient management. J Med Virol. 2021;93(2):606‐607. [DOI] [PubMed] [Google Scholar]
  • 18. Awan UA, Zahoor S, Ayub A, Ahmed H, Aftab N, Afzal MS. COVID‐19 and arboviral diseases: another challenge for Pakistan's dilapidated healthcare system. J Med Virol. 2020;93:4065‐4067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Franklinos L, Jones KE, Redding DW, Abubakar I. The effect of global change on mosquito‐borne disease. Lancet Infect Dis. 2019;19(9):e302‐e312. [DOI] [PubMed] [Google Scholar]
  • 20. Fatima Z, Afzal S, Idrees M, et al. Change in demographic pattern of dengue virus infection: evidence from 2011 dengue outbreak in Punjab, Pakistan. Public Health. 2013;127(9):875‐877. [DOI] [PubMed] [Google Scholar]
  • 21. Eder M, Cortes F, Teixeira de Siqueira Filha N, et al. Scoping review on vector‐borne diseases in urban areas: transmission dynamics, vectorial capacity and co‐infection. Infect Dis Poverty. 2018;7(1):1‐24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Butt MH, Ahmad A, Misbah S, et al. Ensuring the quality and appropriate use of hand sanitizers during the Covid‐19 pandemic; suggestions and recommendations with role of the pharmacist. Disaster Med Public Health Prep. 2021:1‐2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES